One noteworthy finding of this study is that the presence of anti‐AGO or anti‐FGFR3 antibodies, which clinically delineate subgroups of SNN or associate with autoimmune conditions like Sjögren's syndrome, did not correlate with any distinctive cytokine profile. This evidence concerns the gene FGFR3 and Sjogren syndrome.